MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the
first studies to compare the protective potential of two
angiotensin receptor blockers in hypertensive patients with
diabetic nephropathy, was presented at the European Society
of Hypertension, Milan. The results from this study show that ...